periodically at each hospital.
Members of the Bacteroides fragilis group are the most frequent and important anaerobic gram-negative human pathogens isolated in intra-abdominal infections (2, 10, 11, 15, 16, 18, 23) . Over the past few years, nationwide studies have demonstrated that these microorganisms have undergone changes in their susceptibility patterns (1-3, 5-8, 10, 13, 16, 21) , as well as in the prevalence of their species (6, 10, 18 Resistance rates varied from one medical center to another. Altogether, 578 strains were analyzed: 337 from Hopital Saint-Luc (B. eggerthii was deleted from the calculations because only 1 strain was isolated), 154 from Hopital EnfantJesus, and 87 from H6pital Hotel-Dieu. All isolates were susceptible to metronidazole and imipenem. For the other antibiotics tested, the following resistance rates were found (Table 2) : cefotetan, 52.8, 39, and 36.8%; cefoxitin, 17.5, 5.2, and 3.4%; clindamycin, 8.9, 7.1, and 10.3% at Hopital SaintLuc, Hopital Enfant-Jesus, and Hopital Hotel-Dieu, respectively. Our results showed more strains resistant to cefotetan and cefoxitin (P < 0.001) at Hopital St-Luc than at the other two centers individually. Moreover, more strains of B. thetaiotaomicron, B. ovatus, and B. distasonis at Hopital St-Luc were found to be resistant to cefoxitin (P < 0.01) and only B. ovatus resistance to cefoxitin achieved statistical significance (P < 0.02). No B. ovatus strains resistant to cefoxitin were found elsewhere than at Hopital Saint-Luc (29.6%).
As Hopital Enfant-Jesus, 2.6%). The highest rates of resistance to cefoxitin (20.7%), cefotetan (61.9%), and clindamycin (17.5%) all occurred at Hopital Saint-Luc. At this center, the highest resistance rate occurred in 1990, the last year of the study, for cefoxitin and in 1987, the first year of the survey, for the other two antimicrobial agents.
DISCUSSION
Anaerobic bacteria are the mainstay of the flora involved in intra-abdominal infections. In contrast to many studies (4, 9, 16, 17, 19, 22) , B. thetaiotaomicron, B. ovatus, and B. distasonis strains, together, were isolated more frequently (42.7%) than B. fragilis (35.4%). The growing number of species within the B. fragilis group requires attentive examination of their frequency of isolation, as well as the antimicrobial susceptibility of each species.
Imipenem and metronidazole were the most potent antimicrobial agents. There were no strains resistant to either agent. These results are in agreement with those of most investigators (1, 5-7, 10, 13, 21, 24) . Fewer strains were resistant to cefoxitin (12.1%) than to cefotetan (46.7%). B. distasonis, B. ovatus, and B. thetaiotaomicron showed the highest rate of resistance to cefotetan. In this respect, our results are similar to those obtained by previous studies (4, 7, 8, 10, 13, 15) , no matter what susceptibility testing technique was used. The most susceptible species were B. fragilis and B. vulgatus. Clindamycin showed good activity overall, with an 8.7% resistance rate. Fewer strains of B. fragilis were resistant to cefoxitin than to clindamycin. We observed fewer strains resistant to clindamy- (12) . The difference between these results is probably due to geographic and demographic differences of the populations studied, as well as the profiles of antibiotic utilization.
Strains recovered at Hopital Saint-Luc were more resistant to cefotetan and cefoxitin than those recovered elsewhere, as seen in Table 2 . Our results showed more B. ovatus, B. distasonis, and B. thetaiotaomicron strains resistant to cefoxitin at Hopital Saint-Luc than at the other two medical centers. Thus, the resistance pattern may fluctuate from one medical center to another, as well as from one geographical region to another. It is not only the relative frequency with which relatively resistant species are isolated but also the antibiotic utilization profile that may cause a difference in the susceptibility pattern between one center and another. Hence, cefotetan was not used at the three medical centers during or before our survey but many analyses of cross-resistance (8, 12) showed that cefoxitin-resistant isolates were highly resistant to cefotetan, the opposite being less true. For instance, Hopital Saint-Luc used cefoxitin many years before the other two centers. During the 4-year study, cefoxitin consumption at Hopital Saint-Luc, HOpital Enfant-Jesus, and Hopital HotelDieu was as follows: 54.9, 85.1, and 15.0 kg, respectively. Even though the number of kilograms of cefoxitin used per bed was higher at Hopital Enfant-Jesus than at Hopital Saint-Luc, the profile of usage was different. Cefoxitin was used for prophylaxis at Hopital Enfant-Jesus, and this may not have allowed time for resistant strains to emerge.
The heterogeneity of species isolation and the striking differences among the resistance rates of the various species illustrate and emphasize the need to pursue the species identification of important clinical isolates to guide empiric therapy of infections caused by these organisms. The changing susceptibility rates over time and the variability in the resistance rates from one hospital to another, except for imipenem and metronidazole, suggest a need for periodic antimicrobial susceptibility testing of each medical center by a referral center.
